ser64

Another Government Approval, Same Setup as Last Time

Long
NASDAQ:MOTS   None
As in January when MOTS had a patent granted by the US and got clearance from the EU, this time they got FDA clearance for their solution for Upper GI Endoscopies. We are seeing the same magnitude of candles on the 2h and 4h charts. I think for a scalp, if you can get in below 1.5, you can hit 1.62 before a pull back in the first few minutes. Otherwise, I think 1.65-1.75 is a solid entry for a run up with key levels at 1.85, 2.05, 2.2, 2.4, 2.6, and 2.7. After 2.05, personally I'll set a ~10% (depending on my entry) trail stop for the entire position.
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.